p-Akt as a potential poor prognostic factor for gastric cancer: a systematic review and meta-analysis
Metrics: PDF 1148 views | HTML 1326 views | ?
Fang Cao1,*, Cong Zhang2,*, Wei Han1, Xiao-Jiao Gao3, Jun Ma4, Yong-Wei Hu1, Xing Gu5, Hou-Zhong Ding1, Li-Xia Zhu5 and Qin Liu5
1Department of General Surgery, Kunshan First People's Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu 215300, P.R. China
2Department of Pharmacy, Kunshan Hospital of TCM, Kunshan, Jiangsu 215300, P.R. China
3Department of Pathology, Kunshan First People's Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu 215300, P.R. China
4Department of Urological Surgery, Kunshan Hospital of TCM, Kunshan, Jiangsu 215300, P.R. China
5Department of Gynaecology and Obstetrics, Kunshan First People's Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu 215300, P.R. China
*These authors have contributed equally to this work
Wei Han, email: firstname.lastname@example.org
Keywords: p-Akt, gastric cancer, prognosis, survival, meta-analysis
Received: January 04, 2017 Accepted: March 17, 2017 Published: April 10, 2017
To understand the relationship between p-Akt expression and the prognosis of patients with gastric cancer, we searched six databases, Pubmed, EMBASE, Cochrane Library, CNKI, Wanfang and CBM for relevant articles in order to conduct this metaanalysis. The pooled hazard ratios and corresponding 95%CI of overall survival were calculated to evaluate the prognostic value of p-Akt expression in patients with gastric cancer. With 2261 patients combined from 13 available studies, the pooled HR showed a poor prognosis in patients with gastric cancer in the univariate analysis (HR=1.88, 95%CI:1.45-2.43, P<0.00001), and the group “univariate analysis+estimate” (HR=1.41, 95%CI: 1.01-1.97, P=0.04), but not in multivariate analysis (HR=0.66, 95%CI: 0.29-1.52, P=0.33) and estimate (HR=1.13, 95%CI: 0.65-1.95, P=0.67). In conclusion, our results indicated that p-Akt was likely to be an indicator of poor prognosis in patients with gastric cancer.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.